Does INSULIN HUMAN Cause Stent placement? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Stent placement have been filed in association with INSULIN HUMAN (Humulin N). This represents 0.0% of all adverse event reports for INSULIN HUMAN.
7
Reports of Stent placement with INSULIN HUMAN
0.0%
of all INSULIN HUMAN reports
0
Deaths
5
Hospitalizations
How Dangerous Is Stent placement From INSULIN HUMAN?
Of the 7 reports, 5 (71.4%) required hospitalization.
Is Stent placement Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INSULIN HUMAN. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does INSULIN HUMAN Cause?
Blood glucose increased (8,704)
Blood glucose decreased (2,587)
Drug ineffective (2,464)
Incorrect dose administered (1,949)
Visual impairment (1,402)
Hypoglycaemia (1,350)
Wrong technique in product usage process (1,163)
Glycosylated haemoglobin increased (1,008)
Blood glucose abnormal (900)
Maternal exposure during pregnancy (865)
What Other Drugs Cause Stent placement?
RANOLAZINE (593)
EVOLOCUMAB (244)
ADALIMUMAB (227)
ROSIGLITAZONE (196)
ETANERCEPT (174)
CLOPIDOGREL BISULFATE (167)
RIVAROXABAN (122)
ASPIRIN (118)
APIXABAN (116)
MACITENTAN (108)
Which INSULIN HUMAN Alternatives Have Lower Stent placement Risk?
INSULIN HUMAN vs INSULIN LISPRO
INSULIN HUMAN vs INSULIN LISPRO-AABC
INSULIN HUMAN vs INSULIN NOS
INSULIN HUMAN vs INSULIN PORK\INSULIN PURIFIED PORK
INSULIN HUMAN vs INTERFERON